Stockreport

OS Therapies Receives Patent Notice of Allowance from U.S. Patent & Trademark Office Covering Commercial Manufacturing of OST-HER2

OS Therapies Incorporated  (OSTX) 
PDF Patent Term Adjustment will provide market exclusivity in the United States into 2040 for all therapeutic indications NEW YORK--(BUSINESS WIRE)--OS Therapies, Inc. (N [Read more]